Paul Woodard joined Bellicum in November 2017 as Vice President, Clinical Development and is responsible for clinical development strategy, clinical trial design, and medical oversight of the Company’s portfolio. He most recently served as Global Development Team Leader for TECENTRIQ® in Hematology at Genentech. Prior to Genentech, Dr. Woodard held positions of increasing responsibility in clinical development and medical affairs at PDL BioPharma, Exelixis, and Amgen. Earlier in his career, he spent eight years at St. Jude Children’s Research Hospital, where his area of clinical and research interest was in pediatric bone marrow transplantation. Mr. Woodard received both his B.A. and M.D. from the University of North Carolina.